MAK Capital Fund reported a 4.5% stake in Protalix BioTherapeutics PLX · 3,616,289 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 4.5%
Last report: 5.8% · filed 26/03/04
Shares held: 3,616,289 sh
Class: Common Stock, $0.001 par value per share
Stock: Protalix BioTherapeutics PLX
Holder: MAK Capital Fund
Event date: 26/03/24
Filed: 26/03/30

4.5% stake · below 5%

Stake: 4.5%
Last report: 5.8%
Since last report: −1.3pp

Protalix BioTherapeutics trades, last 26 weeks

What else happened in Protalix BioTherapeutics around then

Filed or reported within 30 days of the trade day · 02/22~04/23

MAK Capital Fund's other 5% stake reports

MAK Capital Fund
5% stakeComstock
5% stake
Comstock
LODE
6.7% stake
5,065,656 sh
6.7% stake
Filed 09/16
MAK Capital Fund
5% stakeStandard Biotools
5% stake
Standard Biotools
LAB
6.7% stake
26,172,626 sh
6.7% stake
Filed 05/15
MAK Capital Fund
5% stakeAutolus Therapeutics
5% stake
Autolus Therapeutics
AUTL
12.6% stake
33,621,487 sh
12.6% stake
Filed 05/15
MAK Capital Fund
5% stakeEvotec
5% stake
Evotec
EVO
7.1% stake
12,681,898 sh
7.1% stake
Filed 05/01
MAK Capital Fund
5% stakeEvotec
5% stake
Evotec
EVO
7% stake
12,503,512 sh
7% stake
Filed 04/06

MAK Capital Fund reported a 4.5% stake in Protalix BioTherapeutics PLX · 3,616,289 sh · amendment · passive holder | Whalegun